112949 ⎘
Oligonucleotides characterized by their use Screening for pharmacological compounds
Methods of identifying small molecules for renewals, survival and migration of cardiac progenitors
#2102GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
#2103USES AND METHODS RELATING TO NDR KINASE EXPRESSION AND/OR ACTIVITY
#2104Method of diagnosing poor survival prognosis colon cancer using microRNA-21
#2105Transgenic animals comprising gene fusions
#2106BLOOD BIOMARKERS FOR MOOD DISORDERS
#2107Genes based on thalidomide, valproic acid and methotrexate treatment for screening of drug inducing teratogenicity and screening method using thereof
#2108DIAGNOSTICS AND THERAPEUTICS FOR OSTEOPOROSIS
#2109Single cell gene expression for diagnosis, prognosis and identification of drug targets
#2110Gene Expression Profiling for Identification, Monitoring and Treatment of Breast Cancer
#2111MicroRNA Signatures in Human Ovarian Cancer
#2112GENE INVOLVED IN IMMORTALIZATION OF HUMAN CANCER CELL AND USE THEREOF
#2113MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571
#2114NOVEL MEDICAL DIAGNOSTIC METHOD AND THERAPY IN THE CONTEXT OF INTERFREON-STIMULATED GENES THAT INDUCE DEPRESSION
#2115GENE EXPRESSION PROFILING FOR IDENTIFICATION, MONITORING AND TREATMENT OF MELANOMA
#2116METHODS TO IDENTIFY MODULATORS OF B-RAF PROTEIN KINASE AND THEIR USE FOR THE TREATMENT OF ANXIETY AND DEPRESSION
#2117HEYL as a therapeutic target and a diagnostic marker for neoplasia and uses therefor
#2118METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC MYELOID LEUKEMIA AND ACUTE LYMPHOBLASTIC LEUKEMIA
#2119Gene defects and mutant ALK kinase in human solid tumors
#2120EGFR/NEDD9/TGF-BETA INTERACTOME AND METHODS OF USE THEREOF FOR THE IDENTIFICATION OF AGENTS HAVING EFFICACY IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
#2121METHODS OF ANALYSIS AND DETECTING MOLECULAR DEFECTS IN TRANSCOBALAMIN I DEFICIENCY
#2122Detection of CXADR protein for diagnosis of kidney cancer
#2123Enigma-Mdm2 interaction and uses thereof
#2124GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF
#2125Patterns of known and novel small RNAS in human cervical cancer
#2126NON-INVASIVE TECHNIQUE FOR CONDUCTING SKIN INFLAMMATORY DISEASE PHARMACO-GENOMIC STUDIES AND DIAGNOSES THEREOF
#2127TRANSPLANT REJECTION MARKERS
#2128METHOD TO PREDICT RESPONSE TO TREATMENT FOR PSYCHIATRIC ILLNESSES
#2129Gene Expression Profiling for Identification, Monitoring and Treatment of Prostate Cancer
#2130Method for determining inflammatory disease
#2131Gene Expression Profiles and Methods of Use
#2132Gene products differentially expressed in cancerous cells
#2133Differential Drug Sensitivity
#2134Compositions comprising MIR34 therapeutic agents for treating cancer
#2135Combination therapy for treating cancer and diagnostic assays for use therein
#2136Diagnosis and Treatment of Noonan Syndrome and Neoplastic Disorders
#2137Method of predicting a predisposition to QT prolongation
#2138COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING IRRITABLE BOWEL SYNDROME
#2139Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
#2140Prostate cancer-related compositions, methods and kits based on DNA macroarray proteomics platforms
#2141Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#2142BIOMARKER OF ALLERGIC DISEASE AND USE OF THE SAME
#2143Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer as related to MetAP2 expression
#2144Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
#2145Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
#2146WISP POLYPEPTIDES AND NUCLEIC ACIDS ENCODING SAME
#2147METHODS OF IDENTIFYING AND USING SNAIL1 INHIBITORY COMPOUNDS IN CHONDRODYSPLASIA TREATMENT AND PREPARATION OF PHARMACEUTICAL COMPOSITIONS
#2148Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
#2149NOVEL COMPOSITIONS AND METHODS IN CANCER ASSOCIATED WITH ALTERED EXPRESSION OF PRLR
#2150Method
#2151USE OF POLYMORPHISMS IN THE TMEM132D GENE IN THE PREDICTION AND TREATMENT OF ANXIETY DISORDERS
#2152Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
#2153Human Dickkopf-related protein and nucleic acid molecules and uses therefor
#2154Gene Expression Profiling for Identification, Monitoring and Treatment of Ovarian Cancer
#2155SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH AMYOTROPHIC LATERAL SCLEROSIS
#2156Ras mutation and compositions and methods related thereto
#2157Mixed lineage kinases and metabolic disorders
#2158METHOD FOR TREATMENT OF PROSTATE CANCER AND SCREENING OF PATIENTS BENEFITING FROM SAID METHOD
#2159PREVENTIVE/REMEDY FOR CANCER
#2160Compositions for Identifying Novel Compositions for the Treatment of Disease and Methods of Using Same
#2161MULTIPLE MECHANISMS FOR MODULATION OF JAK/STAT ACTIVITY
#2162Nuclear localization of Src-family tyrosine kinases is required for growth factor-induced euchromatinization
#2163Gene Expression Profiling for Identification, Monitoring, and Treatment of Ocular Disease
#2164Methods and compositions for detecting colon cancers
#2165Normal-tension glaucoma model and method for evaluation of test substances by using same
#2166Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma
#2167Profiling for Determination of Response to Treatment for Inflammatory Disease
#2168GENETIC POLYMORPHISMS ASSOCIATED WITH MYOCARDIAL INFARCTION AND USES THEREOF
#2169Pestivirus species
#2170MICRORNA MOLECULES ASSOCIATED WITH INFLAMMATORY SKIN DISORDERS
#2171Methods for Diagnosing Ischemia
#2172IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer
#2173Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer
#2174Methods for Diagnosis and Treatment of Endometrial Cancer
#2175Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related Thereto
#2176PROGNOSTIC FACTOR IN SARCOMA, AND METASTASIS INHIBITOR
#2177TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS
#2178Genetic variants increase the risk of age-related macular degeneration
#2179TUMOR SUPPRESSOR DESIGNATED TS10Q23.3
#2180GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
#2181IRAK-1 AS REGULATOR OF DISEASES AND DISORDERS
#2182IDENTIFICATION OF A PIN SPECIFIC GENE AND PROTEIN (PIN-1) USEFUL AS A DIAGNOSTIC TREATMENT FOR PROSTATE CANCER
#2183Ultraconserved regions encoding ncRNAs
#2184Methods for treatment of type 1 diabetes
#2185ARRAYS AND METHODS COMPRISING M. SMITHII GENE PRODUCTS
#2186Tyrosine kinome
#2187Allelic Form of the HMGA2 Gene Predisposing Women to the Formation of Leiomyomas
#2188PERIPHERICAL TISSUE SAMPLE CONTAINING CELLS EXPRESSING THE 5HTR2C AND/OR ADARS AS MARKERS OF THE ALTERATION OF THE MECHANISM OF THE 5HTR2C MRNA EDITING AND ITS APPLICATIONS
#2189Gene Expression Profiling for Identification, Monitoring and Treatment of Lung Cancer
#2190Netrin-1 as a biomarker of injury and disease
#2191NOL3 is a predictor of patient outcome
#2192Bifunctional Predictors of Cancer Treatment Sensitivity and Resistance
#2193Expressed pseudogene regulates gene expression
#2194KIF11 and method for diagnosing non-small cell lung cancer
#2195METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING MABA1
#2196Endometrial biomarkers
#2197BIOMARKERS FOR BISPHOSPHONATE-RESPONSIVE BONE DISORDERS
#2198DIAGNOSIS AND TREATMENT OF DISEASES CAUSED BY MISFOLDED PROTEINS
#2199Pluripotent cell lines and methods of use thereof
#2200METHODS AND AGENTS FOR EVALUATING INFLAMMATORY BOWEL DISEASE, AND TARGETS FOR TREATMENT
#2201Gammaretrovirus associated with cancer
#2202Novel therapeutic and diagnostic products and methods
#2203Gastric carcinoma gene ZNF312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same
#2204Methods For Detection Of Sepsis
#2205FXDY5 MODULATORS FOR TREATING, DIAGNOSING, AND DETECTING CANCER
#2206Cancer markers
#2207MEANS AND METHODS FOR DIAGNOSING AND TREATING CANCER BASED ON THE FRMD3 GENE
#2208DIAGNOSIS AND TREATMENT OF CERVICAL CANCER
#2209Detection of Unhealthy Cell and Uses Thereof
#2210DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
#2211Methods using PBK1 for identifying agents that treat metabolic disorders
#2212Methods for Differentiating Pancreatic Cancer from Normal Pancreatic Function and/or Chronic Pancreatitis
#2213CANCER CELL IDENTIFICATION MARKER AND CANCER CELL PROLIFERATION INHIBITOR
#2214Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
#2215QUALITATIVE DIFFERENTIAL SCREENING
#2216Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
#2217Alpha-synuclein kinase
#2218TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA
#2219METHODS AND PRODUCTS FOR DIAGNOSING CANCER
#2220FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs
#2221MIF AGONISTS AND ANTAGONIST AND THERAPEUTIC USES THEREOF
#2222METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#2223INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS
#2224Compositions and methods for characterizing and regulating olfactory sensation
#2225Biomarkers for predicting prostate cancer progression
#2226IDENTIFICATION AND VERIFICATION OF METHYLATION MARKER SEQUENCES
#2227Diagnosis and treatment of T-cell acute lymphoblastic leukemia
#2228Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
#2229SPINK1 AS A PROSTATE CANCER MARKER AND USES THEREOF
#2230Method for Determining Phospholipidosis
#2231COMPOSITIONS AND METHODS FOR DIAGNOSIS OR PROGNOSIS OF TESTICULAR CANCER
#2232MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma
#2233IDENTIFICATION OF POLYNUCLEOTIDES FOR PREDICTING ACTIVITY OF COMPOUNDS THAT INTERACT WITH AND/OR MODULATE PROTEIN TYROSINE KINASES AND/OR PROTEIN TYROSINE KINASE PATHWAYS IN PROSTATE CELLS
#2234Biomarkers For Assessing Altherosclerotic Potential
#2235BIOMARKERS FOR SERIOUS SKIN RASH
#2236GENETIC VARIANTS USEFUL FOR RISK ASSESSMENTS OF CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION
#2237METHODS FOR DETECTING AND TREATING KIDNEY DISEASE
#2238Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#2239Compositions and Methods for Prognosis, Diagnosis, Prevention and Treatment of Cancers
#2240Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
#2241Microrna molecules
#2242BCR-ABL variants
#2243METHOD FOR PREDICTING THE RESPONSE TO A TREATMENT
#2244TRANSCRIPTOMIC BIOMARKERS FOR INDIVIDUAL RISK ASSESSMENT IN NEW ONSET HEART FAILURE
#2245VIPR1S as Modifiers of the E2F/RB Pathway and Methods of Use
#2246Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
#2247Antigen polypeptide for the diagnosis and/or treatment of ovarian cancer
#2248METHOD OF CANCER DETECTION AND TREATMENT
#2249Stroma Derived Predictor of Breast Cancer
#2250METHOD OF SCREENING TEST SUBSTANCES FOR TREATING OR PREVENTING A DISEASE MEDIATED BY PLASMA CELLS
#2251DNP63A gene and screening methods of anticancer agent by using it
#2252Detecting and treating dementia
#2253Methods for Diagnosing and Treating Graft Rejection and Inflammatory Conditions
#2254TREX1 AS A MARKER FOR LUPUS ERYTHEMATOSUS
#2255Biomarker specific for cancer
#2256MicroRNA molecules
#2257Methods for Analysis of Hedgehog Pathway Inhibitors
#2258METHOD FOR IDENTIFYING AN INTESTINAL PHENOTYPE
#2259METHODS FOR TREATING, DIAGNOSING, AND MONITORING LUPUS
#2260CROHN DISEASE SUSCEPTIBILITY GENE
#2261ICBP90 POLYPEPTIDE AND ITS FRAGMENTS AND POLYNUCLEOTIDES CODING FOR SAID POLYPEPTIDES AND APPLICATIONS FOR DIAGNOSING AND TREATING CANCER
#2262MicroRNA molecules
#2263Agents for reversing epigenetic silencing of genes
#2264Genes and polypeptides relating to human pancreatic cancers
#2265USE AND IDENTIFICATION OF BIOMARKERS FOR GASTROINTESTINAL DISEASES
#2266Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene
#2267METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
#2268Microrna molecules
#2269MicroRNA molecules
#2270BRM EXPRESSION AND RELATED DIAGNOSTICS
#2271Method for detecting endometriosis in a patient sample
#2272Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
#2273GENETIC SUSCEPTIBILITY VARIANTS OF TYPE 2 DIABETES MELLITUS
#2274Methods for characterizing and treating cognitive impairment in aging and disease
#2275CANCER ASSOCIATED PROTEIN KINASES AND THEIR USES
#2276CRTAC AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET
#2277MO-1, A Gene Associated With Morbid Obesity
#2278METHOD OF EVALUATING COMPOUND EFFICACIOUS IN TREATING OBESITY BY USING Slc25a10
#2279Perinucleolar compartment as a cancer marker
#2280COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER
#2281POLYMORPHISMS IN GENES AFFECTING CNS DISORDERS AND USES THEREOF
#2282MARKER GENES FOR USE IN THE IDENTIFICATION OF CHONDROCYTE PHENOTYPIC STABILITY AND IN THE SCREENING OF FACTORS INFLUENCING CARTILAGE PRODUCTION
#2283Genetic susceptibility variants associated with cardiovascular disease
#2284DDR2 in Cancer Diagnosis, Detection and Treatment
#2285Methods for the diagnosis and treatment of lung cancer
#2286Brain Endothelial Cell Expression Patterns
#2287Methods and compositions for treating and diagnosing diseases
#2288MN/CA9 Splice Variants
#2289METHODS FOR SCREENING AND TREATMENT INVOLVING THE GENES GYPC, AGPAT3, AGL, PVRL2, HMGB 3, HSDL2 AND/OR LDB2
#2290ADIPONECTIN FOR THE TREATMENT AND DIAGNOSIS OF ALBUMINURIA
#2291Expression profile of thyroid cancer
#2292Molecular signature representative of dysfunctions in epidermal homeostasis
#2293SLIT2 underexpression in metastatic prostate cancer
#2294Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571
#2295Methods for diagnosis of common acute lymphoblastic leukemia by determining the level of gene expression
#2296Role of miRNA in T cell leukemia
#2297Methods for predicting and treating tumors resistant to drug, immunotherapy, and radiation
#2298Tumour Suppressor Protein
#2299Compositions and methods for treating diseases associated with T-box and N-Myc
#2300PCA3, PCA3 genes, and methods of use
#2301GENETIC VARIANTS ASSOCIATED WITH PERIODIC LIMB MOVEMENTS AND RESTLESS LEGS SYNDROME
#2302PROSTATE CANCER SURVIVAL AND RECURRENCE
#2303Method for detecting a target nucleic acid comprising two portions using probes having a first portion complementary to the first portion of the target nucleic acid and a second portion substantially complementary to the second portion of the target nucleic acid
#2304SMALL MOLECULE MODULATORS OF P53 FAMILY SIGNALING
#2305Assessment of risk for colorectal cancer
#2306METHODS FOR IDENTIFYING MUTATIONS IN CODING AND NON-CODING DNA
#2307Cell-based screening assays for compounds that regulate the expresion of a tumor marker dj-1
#2308Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors
#2309Modulating mxa expression
#2310METHOD FOR ESTABLISHING THE SOURCE OF INFECTION IN A CASE OF FEVER OF UNCLEAR AETIOLOGY
#2311Circulating Mutant DNA to Assess Tumor Dynamics
#2312COMPOSITION AND METHODS FOR THE DETECTION OF CRIPTO-3
#2313Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
#2314Method for detecting oral squamous-cell carcinoma
#2315Biomarkers for Drug-Induced Liver Injury
#2316GENETIC VARIATIONS ASSOCIATED WITH TUMORS
#2317IDENTIFICATION OF CANCER STEM CELLS USING GENETIC MARKERS
#2318Metastasis Promoting Genes and Proteins
#2319Method For Identification of Compound Having Anti-Anxiety Effect
#2320T315A AND F317I MUTATIONS OF BCR-ABL KINASE DOMAIN
#2321METHODS FOR DIAGNOSING OSTEOARTHRITIS
#2322LTBP2 as a biomarker and diagnostic target
#2323Methods of Inducing Weight Loss
#2324Methods of treating smooth muscle cell disorders
#2325VH4 codon signature for multiple sclerosis
#2326Stimulus-elicited genomic profile markers of alzheimer's disease
#2327MAMMALIAN OOCYTE DEVELOPMENT COMPETENCY GRANULOSA MARKERS AND USES THEREOF
#2328Using genetic polymorphisms of the BICD1 gene as a method for diagnosing and treating myopia
#2329Compositions comprising MG29 nucleic acids, polypeptides, and associated methods of use
#2330PRRG4-associated compositions and methods of use thereof in methods of tumor diagnosis
#2331Diagnosing, monitoring and treating inflammation
#2332CTIP2 expression in squamous cell carcinoma
#2333CANCER-LINKED GENES AS BIOMARKERS TO MONITOR RESPONSE TO IMPDH INHIBITORS
#2334Method of hepatocellular carcinoma classification and prognosis
#2335Diagnostic and therapeutic methods
#2336Methods of using F-spondin as a biomarker for cartilage degenerative conditions and bone diseases
#2337MicroRNA (miRNA) for the diagnosis and treatment of heart diseases
#2338TTK AS TUMOR MARKER AND THERAPEUTIC TARGET FOR LUNG CANCER
#2339Methods and compositions for diagnosing prostate cancer
#2340METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF CARDIOVASCULAR FUNCTION AND DISORDERS
#2341RBP4 in insulin sensitivity/resistance, diabetes, and obesity
#2342Compositions and methods for detecting Noonan syndrome
#2343Methods and compositions for detecting colon cancers
#2344Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
#2345METHOD FOR IDENTIFYING THERAPEUTICAL TARGETS IN TUMORS, THE USE THEREOF AND MEANS FOR DETERMINING AND TARGETING ANGIOGENESIS AND HEMOSTASIS RELATED TO ANDENOCARCINOMAS OF THE LUNG
#2346GENETIC POLYMORPHISMS ASSOCIATED WITH AUTOINFLAMMATORY DISEASES, METHODS OF DETECTION AND USES THEREOF
#2347Toll like receptor 4 dysfunction and the biological applications thereof
#2348Use of Methylation Status of MINT Loci as a Marker for Rectal Cancer
#2349Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
#2350CHARACTERIZING PROSTATE CANCER
#2351Diagnosis of nasopharyngeal carcinoma and suppression of nasopharyngeal carcinoma invasion
#2352Agents for treatment or prevention of an allergic disorder
#2353Gene Expression Profiles Associated with Asthma Exacerbation Attacks
#2354Genetic markers for risk management of atrial fibrillation, atrial flutter, and stroke
#2355KLF6 ALTERNATIVE SPLICE FORMS AND A GERMLINE KLF6 DNA POLYMORPHISM ASSOCIATED WITH INCREASED CANCER RISK
#2356NOVEL SIGNATURE SELF RENEWAL GENE EXPRESSION PROGRAMS
#2357GENE ASSOCIATED WITH ARTERIOSCLEROTIC DISEASE, AND USE THEREOF
#2358Novel human protein kinase, phosphatase, and protease family members and uses thereof
#2359Methods for inducing the differentiation of hematopoietic stem cells into megakaryocytes and platelets, and gene controlling the differentiation
#2360Antibodies to PRO352
#2361β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
#2362METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF
#2363METHOD OF DIAGNOSING SMALL CELL LUNG CANCER
#2364Cancer Related Genes (PTPE)
#2365Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
#2366Methods and compositions related to GABA receptor subunits
#2367Method
#2368NMU-GHSR1b/NTSR1 oncogenic signaling pathway as a therapeutic target for lung cancer
#2369Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
#2370Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
#237112 human secreted proteins
#2372Cancer-associated antigen
#2373METHODS AND COMPOSITIONS FOR DIAGNOSIS, MONITORING AND DEVELOPMENT OF THERAPEUTICS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE
#2374SCREENING METHOD TO IDENTIFY PROTECTIVE SUBSTANCES FOR THE TREATMENT OF NEURODEGENERATIVE AND/OR ISCHAEMIC DISEASES
#2375Skin aging marker and technique for use thereof
#2376TEM8 GENE, EXPRESSION FORMS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#2377Biomarkers for chronic transplant dysfunction
#2378METHODS FOR DIAGNOSING AND PREDICTING NON-ALCOHOLIC STEATOHEPATITIS (NASH)
#2379DIAGNOSIS AND TREATMENT OF KAWASAKI DISEASE
#2380METHODS TO IDENTIFY POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES WHICH MAY BE ASSOCIATED WITH PHYSIOLOGICAL AND MEDICAL CONDITIONS
#2381Methods of screening for compounds that reduce microbial resistance to fluoroquinolones
#2382DETECTION AND TREATMENT OF CANCERS
#2383Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#2384METHOD FOR TESTING DRUG SENSITIVITY IN SOLID TUMORS BY QUANTIFYING MRNA EXPRESSION IN THINLY-SLICED TUMOR TISSUE
#2385Diagnostic Methods for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapy
#2386Diagnosis And Treatment of Immune-Related Diseases
#2387Compositions, kits, and methods for identification, assessment, prevention and treatment of pancreatic adenocarcinoma in humans
#2388Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
#2389MODULATION OF STAT 6 EXPRESSION
#2390Genetic profiles associated with the 957C>T polymorphism in the DRD2 gene
#2391Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer
#2392Novel Gene Disruptions, Compositions and Methods Relating Thereto
#2393Short interfering RNAs targeted to T-LAK cell-originated protein kinase (TOPK) polynucleotide
#2394Modulation of insulin like growth factor I receptor expression
#2395Methods for assessing efficacy of chemotherapeutic agents
#2396MicroRNA Expression Profiling and Uses Thereof
#2397MUTANT JAK3 KINASE IN HUMAN LEUKEMIA
#2398Androgen Receptor Related Methods for Treating Bladder Cancer
#2399USE OF FREE CIRCULATING DNA FOR DIAGNOSIS, PROGNOSIS, AND TREATMENT OF CANCER FUNDING
#2400Methods of diagnosing and treating parp-mediated diseases